Showing 321 - 340 results of 381 for search '(( 50 ((meer decrease) OR (mean decrease)) ) OR ( 16 ((b decrease) OR (a decrease)) ))', query time: 0.15s Refine Results
  1. 321
  2. 322

    Quercetin Loaded Silica and Gold - Coated Silica Nanoparticles: Characterization, Evaluation and Comparison of Their in vitro Characteristics by Areen M., Khattabi

    Published 2023
    “…The drug was encapsulated in silica NPs in a high percentage (71%) and reduced by about 16% after gold coating. …”
    Get full text
    Get full text
    Get full text
  3. 323
  4. 324

    Mechanical Behavior of a Novel Nanocomposite Polysulphone - Carbon Nanotubes Membrane for Water Treatment by Wang, Kui

    Published 2016
    “…m and outer diameters of 10 nm to 20 nm (corresponded aspect ratios ranging from 50 to 1000), with purity >95% and BET surface area of 156 m2/g. …”
    Get full text
    Get full text
  5. 325

    Performance of sustainable concrete incorporating treated domestic wastewater, RCA, and fly ash by Abushanab, Abdelrahman

    Published 2022
    “…This study evaluates the impact of using treated wastewater (TWW), recycled concrete aggregates (RCA), and fly ash (FA) on the mechanical, durability, and microstructural properties of concrete. A total of eight concrete mixes were manufactured and tested. …”
    Get full text
    Get full text
  6. 326
  7. 327

    Freezing-Based Acid Gas Removal and Its Integration with the Cold Section in an LNG Plant by Pal, Ajinkya

    Published 2022
    “…The results showcase that the proposed integration and structural design changes lower the total energy requirement by 16.6% and increase the production rate by 60 kt/a (1.76%). …”
    Get full text
    Get full text
  8. 328
  9. 329

    Exploring Beyond Numeric Weight Loss: The Metabolic Effects of Semaglutide. by Sara, Sokary

    Published 2025
    “…Also, it enhanced glycemic control, as evidenced by significant reductions in hemoglobin A1C (HbA1c) with the 0.5 mg and 1.0 mg doses. From a baseline range of 8.1–8.7%, 0.5mg dose lowered HbA1c by 1.2–1.5%, while the 1.0 mg dose reduced it by 1.4–1.8%. …”
    Get full text
    Get full text
    Get full text
    article
  10. 330
  11. 331
  12. 332
  13. 333

    In patients with Chronic Heart Failure Which Polypharmacy Pheno-groups are associated with adverse health outcomes? (Polypharmacy Pheno-groups and Heart failure outcomes) by Mohammed Ibn-Mas'ud, Danjuma

    Published 2023
    “…Patient cohorts with excessive polypharmacy (≥9 medications) had the highest probability of survival up to 1.6 years compared to those with lower medication thresholds (≤4); the mortality rate decreased by 18% for patients with excessive polypharmacy [HR=0.82, 95% CI: 0.71 – 0.94]). …”
    Get full text
    Get full text
    Get full text
  14. 334
  15. 335
  16. 336
  17. 337
  18. 338

    Metabolic consequences of obesity on the hypercoagulable state of polycystic ovary syndrome. by Moin, Abu Saleh Md

    Published 2021
    “…However, two anticoagulant proteins, vitamin K-dependent protein-S (p < 0.0001) and heparin cofactor-II (p < 0.001) were elevated and prothrombin was decreased (p < 0.05). CRP, as a marker of inflammation, and insulin resistance (HOMA-IR) correlated with 11 and 6 of the clotting proteins, respectively (p < 0.05). …”
    Get full text
    Get full text
  19. 339
  20. 340

    PROFILE OF OXIDATIVE STRESS GENES IN RESPONSE TO OBESITY TREATMENT by AHMED, AMIRA

    Published 2021
    “…Methods: Wild-type CD1 male mice and the knockout of nuclear factor (erythroid-derived 2) like 2 (NrF2) mice were fed a high-fat diet (HFD) for 16 weeks; to induce obesity. …”
    Get full text
    Get full text